Virtus Investment Advisers, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 13,333 shares of HRMY stock, worth $472,921. This represents 0.15% of its overall portfolio holdings.
Number of Shares
13,333
Previous 11,268
18.33%
Holding current value
$472,921
Previous $373,000
12.87%
% of portfolio
0.15%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
47.1MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$181 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$56.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$56 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...